The relation of Graves' ophthalmopathy to circulating thyroid hormone status

被引:21
作者
Kim, JM
LaBree, L
Levin, L
Feldon, SE
机构
[1] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Dept Prevent Med Stat Consultat, Los Angeles, CA 90089 USA
[3] Univ So Calif, Res Ctr, Los Angeles, CA 90089 USA
[4] Univ So Calif, Doheny Eye Inst, Los Angeles, CA 90089 USA
关键词
D O I
10.1136/bjo.88.1.72
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: The risk factors and epidemiological data for Graves' ophthalmopathy with and without abnormal circulating thyroid levels were examined to determine the relation of thyroid dysfunction to ophthalmopathy. Methods: The authors retrospectively evaluated 482 patients seen with Graves' ophthalmopathy. Of these, 413 were classified as having abnormal levels of circulating thyroid hormone (ALTH) and 69 as having normal levels of circulating thyroid hormone (NLTH). Results: Patients in the NLTH group, compared to the ALTH group, were older on average (56 (SD 13.5) v 52 (15.4)) and had a higher age adjusted body mass index (26.1 (0.8) v 23.4 (0.3)). In addition, a higher percentage of NLTH patients had hypercholesterolaemia. Those in the ALTH group were more likely to be female (76% v 51%), to have a family history of thyroid problems, and to have had eye surgery. Conclusion: NLTH and ALTH appear to differ from each other in terms of risk factors and epidemiological characteristics. Additionally, thyroid dysfunction seems to be associated with a more severe ophthalmopathy compared to the euthyroid state.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 28 条
  • [11] COMPARISON OF THYROID STIMULATING ACTIVITIES MEASURED BY CYCLIC-AMP PRODUCTION, THOSE BY RADIOIODINE UPTAKE IN FRTL-5 CELLS AND TSH-BINDING INHIBITORY ACTIVITIES IN PATIENTS WITH HYPERTHYROID AND EUTHYROID GRAVES DISEASES
    KASAGI, K
    HATABU, H
    TOKUDA, Y
    ARAI, K
    IIDA, Y
    KONISHI, J
    [J]. ACTA ENDOCRINOLOGICA, 1988, 117 (03): : 365 - 372
  • [12] THE INCIDENCE OF OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR GRAVES-DISEASE - PROGNOSTIC FACTORS AND THE ROLE OF METHIMAZOLE
    KUNG, AWC
    YAU, CC
    CHENG, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) : 542 - 546
  • [13] STUDIES ON THE OCCURRENCE OF OPHTHALMOPATHY IN GRAVES-DISEASE
    MARCOCCI, C
    BARTALENA, L
    BOGAZZI, F
    PANICUCCI, M
    PINCHERA, A
    [J]. ACTA ENDOCRINOLOGICA, 1989, 120 (04): : 473 - 478
  • [14] *NAT CTR HLTH STAT, 1996, SER CHOL LEV PERS 20
  • [15] *NAT CTR HLTH STAT, 1996, OV PERS 20 YEARS AG
  • [16] *NAT CTR HLTH STAT, 1998, CURR CIG SMOK PERS 1
  • [17] The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E
    OBrien, T
    Katz, K
    Hodge, D
    Nguyen, T
    Kottke, BA
    Hay, ID
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (01) : 17 - 20
  • [18] CIRCULATING LIPIDS AND MINOR ABNORMALITIES OF THYROID-FUNCTION
    PARLE, JV
    FRANKLYN, JA
    CROSS, KW
    JONES, SR
    SHEPPARD, MC
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (05) : 411 - 414
  • [19] THE DIFFERENTIAL DIAGNOSTIC PROBLEMS IN UNILATERAL EUTHYROID GRAVES OPHTHALMOPATHY
    PERRILD, H
    FELDTRASMUSSEN, U
    BECH, K
    AHLGREN, P
    HANSEN, JM
    [J]. ACTA ENDOCRINOLOGICA, 1984, 106 (04): : 471 - 476
  • [20] ANTIBODIES TO ORBITAL TISSUES IN THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    KENDALLTAYLOR, P
    [J]. ACTA ENDOCRINOLOGICA, 1992, 126 (02): : 137 - 142